Stockscreener 앱 받기
0.2535
0.98%
-0.0025
시장 영업 전:
.24
-0.0135
-5.33%
전일 마감가:
$0.256
열려 있는:
$0.25
하루 거래량:
398.68K
Relative Volume:
0.88
시가총액:
$1.91M
수익:
-
순이익/손실:
$-7.35M
주가수익비율:
-0.5511
EPS:
-0.46
순현금흐름:
$-5.48M
1주 성능:
-38.92%
1개월 성능:
-43.67%
6개월 성능:
-79.05%
1년 성능:
-38.16%
1일 변동 폭
$0.23
$0.2582
1주일 범위
$0.23
$0.493
52주 변동 폭
$0.23
$3.30
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Company Profile
명칭
Shuttle Pharmaceuticals Holdings Inc
전화
(240) 403-4212
주소
401 PROFESSIONAL DRIVE, GAITHERSBURG
SHPH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SHPH
Shuttle Pharmaceuticals Holdings Inc
|
0.2535 | 1.91M | 0 | -7.35M | -5.48M | -0.46 |
|
ZTS
Zoetis Inc
|
148.67 | 67.28B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.22 | 45.62B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.71 | 45.01B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
13.65 | 15.60B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
284.73 | 12.77B | 2.76B | 1.11B | 898.10M | 22.77 |
Shuttle Pharmaceuticals Holdings Inc 주식(SHPH)의 최신 뉴스
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) Sees Significant Growth in Short Interest - Defense World
Shuttle Pharmaceuticals (NASDAQ:SHPH) Trading Down 16.7% – Here’s Why - Defense World
Shuttle Pharma files patent for cancer treatment innovation By Investing.com - Investing.com Canada
Shuttle Pharmaceuticals Files Provisional US Patent to Treat Prostrate Cancer - marketscreener.com
Shuttle Pharma files patent for cancer treatment innovation - Investing.com Australia
Shuttle Pharmaceuticals Files Provisional Patent Application For PSMA Ligand Conjugates To Treat Prostate Cancer - marketscreener.com
Shuttle Pharma Developing Pretreatment Diagnostic Blood - GlobeNewswire
Game-Changing Prostate Cancer Treatment: Shuttle Pharma Unveils Breakthrough PSMA Technology - Stock Titan
Head to Head Analysis: Shuttle Pharmaceuticals (NASDAQ:SHPH) vs. Phibro Animal Health (NASDAQ:PAHC) - Defense World
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Shuttle Pharmaceuticals Appoints New Interim CEO and CSO - TipRanks
Shuttle Pharmaceuticals signs consulting deal with Bowery Group By Investing.com - Investing.com Australia
Shuttle Pharmaceuticals signs consulting deal with Bowery Group - Investing.com
Shuttle Pharmaceuticals Holdings IncOn March 21, Enters Consulting Agreement With Bowery ConsultingSEC Filing - Marketscreener.com
Growth Stocks Are Beaten Down. Why It’s Temporary and What Should Be On Your Shopping List Instead - Asianet Newsable
Shuttle Pharmaceuticals (NASDAQ:SHPH) Stock Price Up 3.8% – Should You Buy? - Defense World
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
SHPH stock touches 52-week low at $0.34 amid market challenges - Investing.com
SHPH stock touches 52-week low at $0.34 amid market challenges By Investing.com - Investing.com South Africa
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
SHPHSHUTTLE PHARMACTCLS HLDGS INC Latest Stock News & Market Updates - Stock Titan
Shuttle Pharma Announces Closing Of $5.75 Million Underwritten Offering -March 13, 2025 at 05:39 pm EDT - Marketscreener.com
Shuttle Pharma Secures $5.2M in Public Offering - TipRanks
Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering - GlobeNewswire
Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering - Benzinga
Shuttle Pharma Raises $5.75M: Strategic Boost for Revolutionary Cancer Treatment Trial - StockTitan
Shuttle Pharma appoints new interim co-CEO By Investing.com - Investing.com Australia
This Md. biotech wants to get a cancer treatment to patients. It just tapped an industry outsider as co-CEO. - The Business Journals
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Shuttle Pharma announces $5.75 million stock offering - Investing.com India
Shuttle Pharma announces $5.75 million stock offering By Investing.com - Investing.com Canada
Shuttle Pharma Announces Pricing of $5.75 Million Underwritten Offering -March 12, 2025 at 09:25 am EDT - Marketscreener.com
Shuttle Pharma Announces Pricing of $5.75 Million Underwritten Offering - GlobeNewswire
Shuttle Pharma Secures Critical $5.75M Funding for Revolutionary Cancer Radiation Therapy - StockTitan
4 Artificial Intelligence (AI) Stocks Worth Buying in the Tech Sell-Off - The Globe and Mail
Lucid Group (LCID) Prepares to Sink Into Penny Stock Territory - The Globe and Mail
1 Large-Cap Stock with Solid Fundamentals and 2 to Avoid - The Globe and Mail
Shuttle Pharma appoints new interim co-CEO - Investing.com
Shuttle Pharma Appoints Christopher Cooper as Interim Co-CEO - citybiz
Shuttle Pharmaceuticals appoints Christopher Cooper as interim Co-CEO - TipRanks
Shuttle Pharma Announces Appointment Of Christopher Cooper As Interim Co-CEO To Enhance Business Activities - Marketscreener.com
Shuttle Pharmaceuticals Appoints Christopher Cooper as Co-CEO - TipRanks
Shuttle Pharma Announces Appointment of Christopher Cooper as Interim Co-CEO to Enhance Business Activities - GlobeNewswire
2 Reasons to Watch GE and 1 to Stay Cautious - The Globe and Mail
SHPH stock touches 52-week low at $0.5 amid sharp annual decline - Investing.com Australia
SHPH stock touches 52-week low at $0.5 amid sharp annual decline By Investing.com - Investing.com South Africa
Zscaler: Bullish Pressure Builds, Rapid Price Increase Expected - The Globe and Mail
Shuttle Pharmaceuticals Holdings Inc (SHPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.74%
0.80%
자본화:
|
볼륨(24시간):